Diabetes

  • Diabetes management: Beyond hemoglobin A1c
    Vinni Makin, MBBS, MD, FACE and M. Cecilia Lansang, MD, MPH
    Cleveland Clinic Journal of Medicine September 2019, 86 (9) 595-600; DOI: https://doi.org/10.3949/ccjm.86a.18031

    Other factors include cardiovascular benefit, weight control, hypoglycemia risk, and cost.

  • Gastroparesis
    Amos Lal, MD, Pantea Ebrahimpour, MD and Nitin Trivedi, MD, FACP, FACE
    Cleveland Clinic Journal of Medicine August 2019, 86 (8) 514; DOI: https://doi.org/10.3949/ccjm.86c.08001

    A reader raises questions about diabetic gastroparesis (April 2019).

  • In reply: Gastroparesis
    Ahmad Muneer Sharayah, MD, Noor Hajjaj, MD, Ramy Osman, MD and Douglas Livornese, MD
    Cleveland Clinic Journal of Medicine August 2019, 86 (8) 514; DOI: https://doi.org/10.3949/ccjm.86c.08002
  • Type 2 diabetes: Evolving concepts and treatment
    Eden Miller, DO, Richard B. Aguilar, MD, Mary E. Herman, PhD and Stanley S. Schwartz, MD
    Cleveland Clinic Journal of Medicine July 2019, 86 (7) 494-504; DOI: https://doi.org/10.3949/ccjm.86a.17107

    Preserving beta cells is key. Recent studies provide compelling argument regarding treatments of choice.

  • Pyoderma gangrenosum mistaken for diabetic ulcer
    Michael A. Munoz, MD and Benson A. Babu, MD, MBA, FACP
    Cleveland Clinic Journal of Medicine May 2019, 86 (5) 319-320; DOI: https://doi.org/10.3949/ccjm.86a.19015

    A man with type 2 diabetes, hypertension, anemia, and ulcerative colitis presented with an ulcer on his leg.

  • Gastric outlet obstruction: A red flag, potentially manageable
    Andree H. Koop, MD, William C. Palmer, MD and Fernando F. Stancampiano, MD
    Cleveland Clinic Journal of Medicine May 2019, 86 (5) 345-353; DOI: https://doi.org/10.3949/ccjm.86a.18035

    Presume the cause to be a malignant tumor untill proven otherwise.

  • Metformin for type 2 diabetes January 2019
    Robert S. Moskowitz, MD, FACP
    Cleveland Clinic Journal of Medicine April 2019, 86 (4) 237; DOI: https://doi.org/10.3949/ccjm.86c.04003

    Readers comment about deviation from guidelines during treatment of a patient with rapidly progressive pleural effusion (January 2019) and the effect of metformin on vitamin B12 levels (January 2019).

  • In reply: Metformin for type 2 diabetes January 2019
    Vinni Makin, MBBS, MD, FACE and M. Cecilia Lansang, MD, MPH
    Cleveland Clinic Journal of Medicine April 2019, 86 (4) 237; DOI: https://doi.org/10.3949/ccjm.86c.04004
  • Gastroparesis in a patient with diabetic ketoacidosis
    Ahmad Muneer Sharayah, MD, Noor Hajjaj, MD, Ramy Osman, MD and Douglas Livornese, MD
    Cleveland Clinic Journal of Medicine April 2019, 86 (4) 238-239; DOI: https://doi.org/10.3949/ccjm.86a.18116

    Computed tomography showed new, severe gastric distention. A scan 11 months previously had been normal.

  • Should metformin be used in every patient with type 2 diabetes?
    Vinni Makin, MBBS, MD, FACE and M. Cecilia Lansang, MD, MPH
    Cleveland Clinic Journal of Medicine January 2019, 86 (1) 17-20; DOI: https://doi.org/10.3949/ccjm.86a.18039

    Most patients should receive it, with exceptions. Nevertheless, it is underused.

Pages